Reporte zur Charge ER:ER8729

Symptomtext

Symptoms similar to what "I" experienced when "I" had COVID. Hot flashes with high frequencies; Feel nauseated; Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 22Apr2021, at 09:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19.Patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included hyaluronic acid/glucosamine sulfate/gelatine hydrolysate/ chondroitin sulfate sodium (GLUCOSAMINE CHONDROITIN), amoxicillin (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, at 02:00 the patient experienced symptoms similar to what she experienced when she had COVID, hot flashes with high frequencies, that made her feel nauseated and severe headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hot flashes with high frequencies, that made the patient feel nauseated and severe headache were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.